Chemical Structure (Chemstructure)
Selegiline Hydrochloride Capsule
Product Images NDC 71335-2673
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 71335-2673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl713352673)
This is a package insert for Selegiline Hydrochloride capsules containing 5 mg each. The capsules should be stored in a tight, light-resistant container at room temperature. The usual adult dosage is two capsules daily. The insert includes a QR code for full prescribing information. The capsules are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Ingenus Pharmaceuticals NJ, LLC.*
Adverse Reactions Table (Table Adverse Events V2)
This text provides data on the incidence of treatment-emergent adverse experiences in a placebo-controlled clinical trial comparing selegiline hydrochloride with placebo. The adverse events reported include nausea, dizziness, fainting, abdominal pain, confusion, hallucinations, dry mouth, dyskinesias, headache, vivid dreams, ache, anxiety, tension, anemia, diarrhea, hair loss, insomnia, leg pain, low back pain, malaise, palpitations, urinary retention, lethargy, and weight loss. The number of patients reporting each event is also listed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
